Unique Issues Facing Brand-Compounder Patent Litigation
By Michael Abernathy, Christopher Betti and Michael Sikora · March 5, 2026, 5:55 PM EST
Recent developments involving compounded GLP-1 tablet products have fostered questions about compounding pharmacies as new and substantial sources of prescription drugs, and whether intellectual property disputes may increase....
To view the full article, register now.